Two Sigma Investments’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Sell |
154,977
-28,690
| -16% | -$23.2K | ﹤0.01% | 2929 |
|
|
2025
Q1 | $141K | Sell |
183,667
-48,172
| -21% | -$37K | ﹤0.01% | 2852 |
|
|
2024
Q4 | $296K | Buy |
231,839
+174,906
| +307% | +$223K | ﹤0.01% | 2677 |
|
|
2024
Q3 | $118K | Buy |
56,933
+13,798
| +32% | +$28.6K | ﹤0.01% | 2812 |
|
|
2024
Q2 | $164K | Sell |
43,135
-17,462
| -29% | -$66.5K | ﹤0.01% | 2685 |
|
|
2024
Q1 | $287K | Buy |
60,597
+2,313
| +4% | +$11K | ﹤0.01% | 2508 |
|
|
2023
Q4 | $249K | Buy |
58,284
+45,471
| +355% | +$194K | ﹤0.01% | 2676 |
|
|
2023
Q3 | $39.6K | Sell |
12,813
-26,477
| -67% | -$81.8K | ﹤0.01% | 2755 |
|
|
2023
Q2 | $177K | Buy |
39,290
+16,835
| +75% | +$75.8K | ﹤0.01% | 2589 |
|
|
2023
Q1 | $128K | Sell |
22,455
-29,443
| -57% | -$168K | ﹤0.01% | 2567 |
|
|
2022
Q4 | $313K | Sell |
51,898
-53,703
| -51% | -$324K | ﹤0.01% | 2162 |
|
|
2022
Q3 | $698K | Sell |
105,601
-118,235
| -53% | -$782K | ﹤0.01% | 1580 |
|
|
2022
Q2 | $1.17M | Buy |
223,836
+43,424
| +24% | +$227K | ﹤0.01% | 1428 |
|
|
2022
Q1 | $1.25M | Sell |
180,412
-102,362
| -36% | -$706K | ﹤0.01% | 1566 |
|
|
2021
Q4 | $3.52M | Buy |
+282,774
| New | +$3.52M | 0.01% | 1061 |
|
|
2021
Q3 | – | Sell |
-10,116
| Closed | -$290K | – | 2881 |
|
|
2021
Q2 | $290K | Buy |
+10,116
| New | +$290K | ﹤0.01% | 2137 |
|